Development of a highly sensitive and green first-derivative synchronous fluorescence spectroscopic method for the simultaneous quantification of telmisartan and rosuvastatin: Greenness metric assessment and application to a pharmacokinetic study in rats
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2024-06 · 314 · 124164
DOI: 10.1016/j.saa.2024.124164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2024-06. Verfasst von Sherif Ramzy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, 11751 Nasr City, Cairo, Egypt. Electronic address: ssherif1…. Hauptthemen laut MEDLINE: Antihypertensive Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Princess Nourah bint Abdulrahman University.
Abstract (Originalsprache)
Hypertension and hyperlipidemia frequently coexist and are correlated with elevated cardiovascular adverse outcomes. Fixed dose combination tablets containing antihypertensive and antihyperlipidemic drugs have the potential to improve patient compliance. Telmisartan and rosuvastatin fixed dose combination tablet has been recently formulated. This study provided the first fluorescence spectroscopic method for simultaneously quantifying telmisartan and rosuvastatin in tablet dosage form and plasma. The native fluorescence spectra of telmisartan and rosuvastatin completely overlapped, making direct measurement unachievable. However, through the implementation of synchronous fluorescence measurements of telmisartan and rosuvastatin at a Δλ = 60, distinct narrow bands were observed at 358 nm and 375 nm, respectively. Regrettably, the challenge of overlapping remained unresolved. Nevertheless, by converting these synchronous spectra into first-order spectra, the problem of overlapping was completely resolved. This conversion also allowed for the selective quantification of telmisartan and rosuvastatin at 374 nm and 358 nm, respectively. The validity of this method was confirmed in accordance with ICH guidelines, yielding satisfactory results in terms of the validation characteristics. The method demonstrated linear relationships between the response and the studied drugs concentrations in working range of 50-1000 ng/mL for telmisartan and 100-2000 ng/mL for rosuvastatin. The described methodology was applied for the pharmacokinetic study of telmisartan and rosuvastatin in rat plasma after a single oral dose of 4 mg/kg telmisartan and 50 mg/kg rosuvastatin. Pharmacokinetic analyses revealed a moderate drug-drug interaction between the two drugs, which was not considered to be clinically significant. Moreover, the described method was assessed in terms of sensitivity and environmental sustainability against three previously documented methods. The comparison effectively underscores the supremacy of the proposed technique over the documented techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University, 11751 Nasr City, Cairo, Egypt. Electronic address: ssherif14@azhar.edu.eg.
- Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, 21944 Taif, Saudi Arabia.
- Department of Basic Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
- Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, 21944 Taif, Saudi Arabia; Addiction and Neuroscience Research Unit, Health Science Campus, Taif University, P.O. Box 11099, 2…
Förderung
- Princess Nourah bint Abdulrahman University
Zitieren
APA
Ramzy, S., Abduljabbar, M. H., Alosaimi, M. E., & Almalki, A. H. (2024). Development of a highly sensitive and green first-derivative synchronous fluorescence spectroscopic method for the simultaneous quantification of telmisartan and rosuvastatin: Greenness metric assessment and application to a pharmacokinetic study in rats. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 314, 124164. https://doi.org/10.1016/j.saa.2024.124164
Vancouver
Ramzy S, Abduljabbar MH, Alosaimi ME, Almalki AH. Development of a highly sensitive and green first-derivative synchronous fluorescence spectroscopic method for the simultaneous quantification of telmisartan and rosuvastatin: Greenness metric assessment and application to a pharmacokinetic study in rats. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2024;314:124164. doi:10.1016/j.saa.2024.124164
BibTeX
@article{Ramzy2024,
author = {Ramzy, Sherif and Abduljabbar, Maram H and Alosaimi, Manal E and Almalki, Atiah H},
title = {Development of a highly sensitive and green first-derivative synchronous fluorescence spectroscopic method for the simultaneous quantification of telmisartan and rosuvastatin: Greenness metric assessment and application to a pharmacokinetic study in rats},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2024},
volume = {314},
pages = {124164},
doi = {10.1016/j.saa.2024.124164}
}
EUVIMED